Initiative for Theranostics and Particle Therapy

The Initiative for Theranostics and Particle Therapy (ITPT) is a joint initiative of UW Carbone, UW School of Medicine and Public Health, Wisconsin Alumni Research Foundation and UW Health to strengthen existing research collaborations, create new partnerships and resources, and drive innovative treatments for metastatic cancer patients in Wisconsin and worldwide.

ITPT unites the efforts of researchers whose specialties include targeted radionuclide therapy (TRT) discovery and development, radiobiology, translational radiotherapy, medical physics, advanced imaging, personalized dosimetry, and radio-immunotherapy combinations. In addition to cross-training and educational goals, ITPT resources will support preclinical, translational and clinical research to advance new precision radiopharmaceutical development.

Apply for a Conference Travel Award

ITPT Co-Chairs

Drs. Jamey Weichert, Zachary Morris

Contact ITPT

Featured ITPT Member Spotlights

Faculty Spotlight – Dr. Mike Lawless
Read the interview with Dr. Mike Lawless, Initiative for Theranostics & Particle Therapy Clinical Research & Practice Subcommittee Member
February 26, 2026
Faculty Spotlight – Dr. John Floberg
Read the interview with Dr. John Floberg, Initiative for Theranostics & Particle Therapy Education & Training Subcommittee Member
February 26, 2026
Faculty Spotlight – Dr. Jonathan Engle
Read the interview with Dr. Jonathan Engle, Initiative for Theranostics & Particle Therapy Education & Training Subcommittee Member
February 26, 2026

Upcoming ITPT Seminars

Thursday, February 26 2026 from 3-5pm in HSLC 1309 & virtual – Register Now!

- Dr. Peter Caravan, Ph.D., Harvard Medical School
  - “Development of fibrin-targeted radionuclides for diagnostic imaging and radioligand therapy”

RASR Lab

ITPT oversees the Radiopharmaceutical Analytics and Specimen Research (RASR) laboratory. RASR enables UW Carbone researchers and external partners to store and analyze radioactive tissue samples and thoroughly examine the in vivo metabolism and biology of radiopharmaceuticals. The operational aim of the RASR is to harbor all radioactive analyses within the ITPT in order to streamline regulatory requirements and compliance while maximizing safety. RASR is a secure facility with access limited to approved researchers and staff. RASR equipment that enables state-of-the-art immunophenotyping of radioactive blood and tissues specimens. See full equipment list on their site.